• Protocols

• GOG3069

  OPEN TO ACCRUAL

  Ph2 Study of Alpelisib & Fulvestrant for PIK3CA-mutated Estrogen Receptor Endometrial Cancers
  
  

• UW22048

  OPEN TO ACCRUAL

  Ph1 Study of RLY-2608 in PI3KA Solid Tumors & in Combination with Fulvestrant in PI3KA Breast Cancer